Association between component‐resolved diagnosis of house dust mite and efficacy of allergen immunotherapy in allergic rhinitis patients. Issue 1 (19th December 2019)

• Record Type: Journal Article
• Authors: Huang, Yanran; Wang, Chengshuo; Lin, Xi; Lou, Hongfei; Cao, Feifei; Li, Wenhan; Zhang, Yuan; Zhang, Luo
• Is Part Of: Clinical and translational allergy. Volume 9:Issue 1(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-12-19
• Subjects: Allergic rhinitis -- Allergen immunotherapy -- House dust mite -- Component resolved diagnosis; Allergy -- Periodicals; Immunology -- Periodicals; Allergy and Immunology -- Periodicals; Hypersensitivity -- Periodicals; Immune System Phenomena -- Periodicals; 616.97005
• DOI: 10.1186/s13601-019-0305-4
• Languages: English
• ISSNs: 2045-7022

Abstract

Abstract: Data regarding clinical relevance of house dust mite (HDM) components over allergen immunotherapy (AIT) for allergic rhinitis (AR) are lacking. 18 adult AR patients receiving HDM‐AIT for 52 weeks were followed up to assess serum levels of sIgE and sIgG4 to HDM components. The study showed that Der p1, p2, p23, Der f1 and f2, are important sensitizing components of HDM, of which Der p1 appears to be the most clinically relevant allergenic component for effective AIT.